In T2DM, the c-Jun N-terminal kinase (JNK) pathway is stimulated by the TNF-α cascade, thereby initiating peripheral insulin resistance, causing IRS-1 inhibition at the brain level and the interruption of downstream cascade favoring tau hyperphosphorylation and amyloid assembly. Here, MAPK8 is linked to type 2 diabetes mellitus.